BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16055243)

  • 1. Epidermal growth factor receptor (EGF-R) in Dupuytren's disease.
    Augoff K; Taboła R; Kula J; Gosk J; Rutowski R
    J Hand Surg Br; 2005 Dec; 30(6):570-3. PubMed ID: 16055243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor in Dupuytren's disease.
    Augoff K; Kula J; Gosk J; Rutowski R
    Plast Reconstr Surg; 2005 Jan; 115(1):128-33. PubMed ID: 15622242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatinase A activity in Dupuytren's disease.
    Augoff K; Ratajczak K; Gosk J; Tabola R; Rutowski R
    J Hand Surg Am; 2006 Dec; 31(10):1635-9. PubMed ID: 17145384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupuytren's palmar contracture in women.
    Stahl S; Calif E
    Isr Med Assoc J; 2008 Jun; 10(6):445-7. PubMed ID: 18669144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myofibroblasts of palmar fibromatosis co-express transforming growth factor-alpha and epidermal growth factor receptor.
    Magro G; Lanteri E; Micali G; Paravizzini G; Travali S; Lanzafame S
    J Pathol; 1997 Feb; 181(2):213-7. PubMed ID: 9120728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation and types of Dupuytren's disease.
    Rayan GM
    Hand Clin; 1999 Feb; 15(1):87-96, vii. PubMed ID: 10050245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the extracellular matrix proteoglycan profile in Dupuytren's contracture affect the palmar fascia.
    Koźma EM; Olczyk K; Wisowski G; Głowacki A; Bobiński R
    J Biochem; 2005 Apr; 137(4):463-76. PubMed ID: 15858170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans cells in Dupuytren's contracture.
    Qureshi FI; Hornigold R; Spencer JD; Hall SM
    J Hand Surg Br; 2001 Aug; 26(4):362-7. PubMed ID: 11469841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular structure and biology of Dupuytren's disease.
    Tomasek JJ; Vaughan MB; Haaksma CJ
    Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
    Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
    J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of steroids on Dupuytren's disease: role of programmed cell death.
    Meek RM; McLellan S; Reilly J; Crossan JF
    J Hand Surg Br; 2002 Jun; 27(3):270-3. PubMed ID: 12074617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the fibroblast in Dupuytren's contracture.
    Murrell GA
    Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
    Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
    J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective review of the management of Dupuytren's nodules.
    Reilly RM; Stern PJ; Goldfarb CA
    J Hand Surg Am; 2005 Sep; 30(5):1014-8. PubMed ID: 16182060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
    Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
    Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupuytren's contracture: morphological and biochemical changes in palmar aponeurosis.
    Hamamoto H; Ueba Y; Sudo Y; Sanada H; Yamamuro T; Takeda T
    Hand; 1982 Oct; 14(3):237-47. PubMed ID: 6130030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmar fascial complex anatomy and pathology in Dupuytren's disease.
    Rayan GM
    Hand Clin; 1999 Feb; 15(1):73-86, vi-vii. PubMed ID: 10050244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal behavior of cultured fibroblasts from nodule and nonaffected aponeurosis of Dupuytren's disease.
    Azzarone B; Failly-Crepin C; Daya-Grosjean L; Chaponnier C; Gabbiani G
    J Cell Physiol; 1983 Dec; 117(3):353-61. PubMed ID: 6197420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.